FR2347045B1 - - Google Patents

Info

Publication number
FR2347045B1
FR2347045B1 FR7710129A FR7710129A FR2347045B1 FR 2347045 B1 FR2347045 B1 FR 2347045B1 FR 7710129 A FR7710129 A FR 7710129A FR 7710129 A FR7710129 A FR 7710129A FR 2347045 B1 FR2347045 B1 FR 2347045B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7710129A
Other languages
French (fr)
Other versions
FR2347045A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Publication of FR2347045A1 publication Critical patent/FR2347045A1/fr
Application granted granted Critical
Publication of FR2347045B1 publication Critical patent/FR2347045B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7710129A 1976-04-05 1977-04-04 Composition pharmaceutique a base de 3-methyl-7-n-pentylaminopyrazolo (4,3-d) pyrimidine Granted FR2347045A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67400376A 1976-04-05 1976-04-05

Publications (2)

Publication Number Publication Date
FR2347045A1 FR2347045A1 (fr) 1977-11-04
FR2347045B1 true FR2347045B1 (enrdf_load_html_response) 1980-06-13

Family

ID=24704944

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7710129A Granted FR2347045A1 (fr) 1976-04-05 1977-04-04 Composition pharmaceutique a base de 3-methyl-7-n-pentylaminopyrazolo (4,3-d) pyrimidine

Country Status (4)

Country Link
JP (1) JPS52122633A (enrdf_load_html_response)
CA (1) CA1082599A (enrdf_load_html_response)
FR (1) FR2347045A1 (enrdf_load_html_response)
GB (1) GB1530747A (enrdf_load_html_response)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10060388A1 (de) * 2000-12-05 2002-06-06 Merck Patent Gmbh Verwendung von Pyrazolo [4,3-d]pyrimidinen
ES2351624T3 (es) * 2003-05-06 2011-02-08 Ústav Experimentálni Botaniky Av Cr, V.V.I. (Institute Of Experimental Botany Academy Of Sciences Of The Czech Republic, Pro) Pirazolo[4,3-d]pirimidinas, procedimiento para su preparación y uso.

Also Published As

Publication number Publication date
GB1530747A (en) 1978-11-01
JPS52122633A (en) 1977-10-15
FR2347045A1 (fr) 1977-11-04
CA1082599A (en) 1980-07-29
JPS5627495B2 (enrdf_load_html_response) 1981-06-25

Similar Documents

Publication Publication Date Title
JPS5435217B2 (enrdf_load_html_response)
JPS5373829U (enrdf_load_html_response)
CS178379B1 (enrdf_load_html_response)
BR5600715U (enrdf_load_html_response)
CS178376B1 (enrdf_load_html_response)
CS175117B1 (enrdf_load_html_response)
CS173369B1 (enrdf_load_html_response)
CH600690A5 (enrdf_load_html_response)
CH613906A5 (enrdf_load_html_response)
CH595902A5 (enrdf_load_html_response)
CH596689A5 (enrdf_load_html_response)
CH600301A5 (enrdf_load_html_response)
CH594554A5 (enrdf_load_html_response)
CH601874A5 (enrdf_load_html_response)
CH601972A5 (enrdf_load_html_response)
CH602230A5 (enrdf_load_html_response)
CH602384A5 (enrdf_load_html_response)
CH603034A5 (enrdf_load_html_response)
CH604029A5 (enrdf_load_html_response)
CH604235B5 (enrdf_load_html_response)
CH604339A5 (enrdf_load_html_response)
CH609106A5 (enrdf_load_html_response)
CH609271A5 (enrdf_load_html_response)
CH609492A5 (enrdf_load_html_response)
CH611736A5 (enrdf_load_html_response)

Legal Events

Date Code Title Description
ST Notification of lapse